29 March 2016

Important milestone towards market introduction of Sivanto™ prime in Europe

European Commission approves flupyradifurone

Innovative insecticide for sucking pest control / Product combines efficacy and convenience with excellent safety characteristics / Market launch in Europe planned in 2017

Monheim – Bayer CropScience has reached an important milestone towards the market introduction of its innovative insecticide Sivanto™ prime in Europe, as officially released on November 2, 2015. Its active ingredient flupyradifurone, which belongs to the chemical class of butenolides, has been approved for the maximum time span of 10 years by the European Commission in accordance with Regulation (EC) 1107/2009. Sivanto prime controls a wide range of sucking pests on fruits and vegetables as well as speciality crops such as hops. The approval decision will enter into force after being published in the Official Journal of the European Union. First national registrations of Sivanto prime in European countries are expected in this year and the market introduction is planned for 2017.

“European growers, retailers, the food chain and consumers will all benefit from Sivanto prime,” said Dr. Matthias Haas, responsible Global Project Manager at Bayer CropScience. “It combines efficacy and convenience for the grower with excellent safety characteristics and will lead to better quality of produce. When applied at the proposed label rates, Sivanto prime is not associated with any adverse effects on honey bees and bumble bees.” 

Haas pointed out that Bayer’s core competencies lie in developing and supplying integrated crop solutions that are locally adapted and tailored to the individual needs of its customers. “We are convinced that Sivanto prime will become an important strategic cornerstone of our tailored offer in Europe.”

Sivanto prime has been successfully launched in the USA, Mexico, Nicaragua, Guatemala, Honduras and the Dominican Republic. Applied as a foliar spray or as a soil drench or drip irrigation, Sivanto prime has demonstrated its potential in practice. ”We expect to receive regulatory approval in Canada and Australia by the end of the year,” added Dr. Hans-Werner Rauen, Global Regulatory Affairs Manager Insecticides at Bayer CropScience. For more information on Sivanto prime including a list of registered crops, visit www.sivanto.com.

Due to its selectivity to most beneficials in fruit and vegetable crops, Sivanto prime can be used in Integrated Pest Management (IPM) programs together with biologicals and beneficials. Furthermore, it is a new tool for improved resistance management. Sivanto prime also offers growers great flexibility with regard to timing as it can even be applied during flowering, ensuring crop safety at all growth stages.

About Bayer CropScience
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 9,494 million (2014) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 23,100 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.

Find more information at www.bayercropscience.com.

Forward-Looking Statements 
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. 


Source: http://press.bayer.com/baynews/baynews.nsf/id/European-Commission-approves-flupyradifurone?Open&parent=news-overview-category-search-en&ccm=020